Related Experiment Video
Updated: May 14, 2026

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
Published on: April 7, 2017
The C-terminal putative nuclear localization sequence of breast cancer metastasis suppressor 1, BRMS1, is necessary
Douglas R Hurst1, Yi Xie, John W Thomas
1Department of Pathology, University of Alabama at Birmingham, Birmingham, Alabama, USA. DHurst@uab.edu
Abstract:
Breast cancer metastasis suppressor 1 (BRMS1) is a predominantly nuclear protein that suppresses metastasis in multiple human and murine carcinoma cell lines. BRMS1 interacts with several nuclear proteins including SIN3:HDAC chromatin remodeling complexes that are involved in repressing transcription. However, recent reports suggest BRMS1 may function in the cytoplasm. BRMS1 has two predicted nuclear localization sequences (NLS) that are located near the C-terminus (amino acids 198-205 and 238-244, NLS1 and NLS2 respectively). We hypothesized that nuclear localization sequences of BRMS1 were essential for BRMS1 mediated metastasis suppression. Replacement of NLS2 with NLS1 (BRMS1(NLS1,1)), truncation at 238 (BRMS1(ΔNLS2)), or switching the location of NLS1 and NLS2 (BRMS1(NLS2,1)) did not affect nuclear localization; but, replacement of NLS1 with NLS2 (BRMS1(NLS2,2)) or truncation at 197 (BRMS1(ΔNLS) which removes both NLS) promoted cytoplasmic localization. MDA-MB-231 human metastatic breast cancer cells transduced with BRMS1(NLS1,1), BRMS1(NLS2,2) or BRMS1(NLS2,1) were evaluated for metastasis suppression in an experimental xenograft mouse model. Interestingly, while NLS2 was not necessary for nuclear localization, it was found to be important for metastasis suppression since BRMS1(NLS2,2) suppressed metastasis by 85%. In contrast, BRMS1(NLS2,1) and BRMS1(NLS1,1) did not significantly suppress metastasis. Both BRMS1 and BRMS1(NLS2,2) co-immunoprecipitated with SIN3A in the nucleus and cytoplasm; however, BRMS1(NLS1,1) and BRMS1(NLS2,1) were associated with SIN3A in the nucleus only. Moreover, BRMS1 and BRMS1(NLS2,2), but not BRMS1(NLS1,1) and BRMS1(NLS2,1), down-regulated the pro-metastatic microRNA, miR-10b. Together, these data demonstrate an important role for NLS2 in the cytoplasm that is critical for metastasis suppression and is distinct from nuclear localization.
Insights
Breast cancer metastasis suppressor 1 (BRMS1) protein
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Breast cancer metastasis suppressor 1 (BRMS1) is a protein that inhibits metastasis in various cancer cells.
- BRMS1 primarily functions in the nucleus, interacting with chromatin remodeling complexes.
- Recent findings suggest BRMS1 may also have cytoplasmic functions.
Purpose of the Study:
- To investigate the role of nuclear localization sequences (NLS) in BRMS1-mediated metastasis suppression.
- To determine if cytoplasmic localization of BRMS1 affects its metastasis-suppressing activity.
Main Methods:
- Mutagenesis of BRMS1 to alter its nuclear localization sequences (NLS1 and NLS2).
- Transduction of MDA-MB-231 breast cancer cells with modified BRMS1 variants.
- Evaluation of metastasis suppression in a mouse xenograft model.
- Co-immunoprecipitation assays to assess protein interactions.
- Analysis of microRNA expression (miR-10b).
Main Results:
- BRMS1 variants with altered NLS showed varying degrees of nuclear and cytoplasmic localization.
- BRMS1(NLS2,2), which localizes predominantly to the cytoplasm, suppressed metastasis by 85%.
- BRMS1(NLS2,2) maintained interaction with SIN3A in both nucleus and cytoplasm and downregulated miR-10b.
- BRMS1 variants primarily localized in the nucleus did not significantly suppress metastasis.
Conclusions:
- Nuclear localization sequence 2 (NLS2) plays a critical role in cytoplasmic localization and metastasis suppression, independent of nuclear import.
- Cytoplasmic function of BRMS1, mediated by NLS2, is crucial for inhibiting breast cancer metastasis.
- BRMS1's metastasis-suppressing activity involves regulating pro-metastatic microRNAs like miR-10b.
Related Concept Videos
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Nuclear Localization Signals and Import
MicroRNAs
MicroRNAs
Abnormal Proliferation
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
